AOD 9604: Patient Information & Safety Notes
Also known as AOD9604
Other names: aod9604, hgh-fragment-176-191
AOD 9604 is a synthetic peptide derived from the C-terminal region (amino acids 176–191) of human growth hormone. It has been investigated preclinically and in early clinical trials for its potential effects on fat metabolism. It is NOT approved by the FDA for any indication.
In plain language
What AOD 9604 is used for
- Investigated in research settings for fat metabolism and lipolysis
Taking this medicine
How it is administered
- Subcutaneous injection
- Sublingual troche
- Topical cream
Read before you decide
Risks and precautions
Risks and warnings
- Nausea has been reported in early research
- Injection site irritation
- Long-term safety and efficacy not established in large-scale human trials
Who should not take it
- Personal or family history of cancer (precautionary; growth-hormone-related peptide)
- Pregnancy or breastfeeding
Common questions
Patient questions
Is AOD 9604 FDA-approved?
No. AOD 9604 is not FDA-approved for any indication in the United States. It has been studied in early clinical research, but its safety and effectiveness have not been established. It is not a substitute for FDA-approved weight-management medications.
Related medications
Explore treatment hubs
This information is educational — not medical advice.
This page is provided for general educational purposes and summarizes publicly available data from sources such as the U.S. Food & Drug Administration. It is not a substitute for the judgment of a licensed clinician and should not be used to start, stop, or change any medication. It may be incomplete or out of date, and individual circumstances vary. Always talk with your prescriber or pharmacist about your specific medications and health conditions. If you think you may have a medical emergency, call 911.
Sources & References
Learn more about where our data comes from and how we write and review medical content.